Yeshiva University: Trial of Highly Touted Drug Begins at Montefiore and Einstein
April 30, 2020
April 30, 2020
BRONX, New York, April 30 -- Yeshiva University's Albert Einstein College of Medicine issued the following news release:
Researchers at Montefiore Health System and Albert Einstein College of Medicine have begun testing the drug hydroxychloroquine for the treatment of COVID-19, as part of a nationwide trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI).
"We're actively looking for medications to treat patients with COVID-19," said Michael . . .
Researchers at Montefiore Health System and Albert Einstein College of Medicine have begun testing the drug hydroxychloroquine for the treatment of COVID-19, as part of a nationwide trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI).
"We're actively looking for medications to treat patients with COVID-19," said Michael . . .